跳至主要内容
临床试验/NCT04824495
NCT04824495Unknown不适用

Evaluation of Inflammatory Cytokines During COVID-19

University of Vienna1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年1月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Cytokine level in context with clinical parameters

研究概览

简要总结

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

详细描述

In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Confirmation of acute SARS-CoV2 infection
  • Ability to provide informed consent

排除标准

  • 未提供

结局指标

主要结局

Cytokine level in context with clinical parameters

时间窗: 2 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniela Gompelmann

Prof. Dr. med.

University of Vienna

研究点 (1)

Loading locations...

相似试验

Evaluation of Inflammatory Cytokines During COVID-19 | 临床试验